Eli Lilly announced clinical trial results this week for a daily pill to treat obesity and diabetes. Its name is absolutely ...

Five GLP-1 products will collectively bring in $470 billion by 2030, and the market leaders are working to hold back ...

I n an hour-long meeting at Eli Lilly and Company’s headquarters in Indianapolis on April 15, the pharmaceutical company’s top executives met, like they had dozens of times before, to hear the ...

It seems like a simple question forl Lilly Wachowski: How did she and sibling Lana Wachowski dream up the idea of 1999 cyberpunk classic “The Matrix” involving a future world where our minds ...

Eli Lilly LLY underwent analysis by 7 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table encapsulates their recent ratings, offering a ...

Shares of AstraZeneca (AZN), Pfizer (PFE), Eli Lilly (LLY), Novo Nordisk (NVO), Johnson & Johnson (JNJ), GSK (GSK), and Sanofi (SNY) all declined. Gold futures climbed and the yield on the 10-year ...

Following a three-day selloff amid market turmoil attributed to the Trump administration’s sweeping tariffs announced last week, Eli Lilly (NYSE:LLY) shares traded higher in the premarket on ...

INDIANAPOLIS — Eli Lilly and Company says it's suing an Indianapolis-based weight loss clinic that it claims is misleading patients about drugs being sold. Lilly claims Premier Weight Loss is selling ...

Eli Lilly and Sangamo Therapeutics have entered into a licensing agreement worth over $1.4bn to deliver genomic medicines for central nervous system (CNS) diseases. The deal gives Lilly an exclusive ...

Eli Lilly & Co.’s shares fell Monday morning after the Trump administration spiked a plan late last week to pay for obesity drugs for Medicare patients. The Centers for Medicare and Medicaid ...

Tariff extension to pharma could hit generic drugmakers hardest, given narrow margins and ex-US API sourcing. FDA layoffs, CBER exit, and 503A/503B rule shifts may delay reviews, with GLP-1 ...